This study is for children under 6 years who have Type 1 Diabetes (T1D). The study tests if dasiglucagon, a medicine, is safe and works well to quickly treat low blood sugar (hypoglycemia). Dasiglucagon is given as a single injection under the skin, specifically in the buttocks. The study will see how the body uses and responds to dasiglucagon. The study lasts up to 84 days and includes 3 visits:
- Visit 1: A check-up before the treatment starts.
- Visit 2: The day dasiglucagon is given.
- Visit 3: A safety check about 29 days after the injection.
Key Points to Consider:
- The study lasts up to 84 days with 3 visits.
- Children will get a single dose of dasiglucagon via injection.
- Safety and glucose levels will be closely monitored.
To join, children must have T1D and be under 6 years old. They cannot join if they have allergies to the medicine or certain health issues. The study aims to help manage low blood sugar safely in young children with T1D.
How understandable was the trial content above?
Hard to understand
Easy to understand